Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
Robert DowdLauren H JepsonCourtney R GreenGregory J NormanRoy ThomasKeri LeonePublished in: JMIR diabetes (2023)
Similar to patients with T1D, patients with non-insulin-treated T2D used RT-CGM system features, suggesting beneficial, routine engagement with data by patients and others involved in their care. Motivated patients with diabetes could benefit from RT-CGM coverage.
Keyphrases
- type diabetes
- glycemic control
- newly diagnosed
- end stage renal disease
- healthcare
- electronic health record
- social media
- ejection fraction
- chronic kidney disease
- big data
- cardiovascular disease
- machine learning
- peritoneal dialysis
- insulin resistance
- affordable care act
- deep learning
- clinical practice
- adipose tissue
- patient reported outcomes
- metabolic syndrome
- artificial intelligence
- skeletal muscle
- weight loss